XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer
2006 · British Journal of Cancer · 113 citations
https://doi.org/10.1038/sj.bjc.6603047
J
Jaime Feliú
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
457
Papers
7.2K
Citations
44
h-index
152
i10-index
Jaime Feliú is an academic researcher from Hospital Universitario La Paz. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Pancreatic and Hepatic Oncology Research & Genetic factors in colorectal cancer. The author has an h-index of 44, co-authored 389 publications.
ORCID: 0000-0003-4867-1420Papers by this author
worksColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients
2015 · Oncotarget · 76 citations
https://doi.org/10.18632/oncotarget.3130
Cardiac toxicity: old and new issues in anti-cancer drugs
2008 · Clinical & Translational Oncology · 65 citations
https://doi.org/10.1007/s12094-008-0150-8
Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline
2023 · ESMO Open · 57 citations
https://doi.org/10.1016/j.esmoop.2023.101195
Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review
2021 · ESMO Open · 48 citations
https://doi.org/10.1016/j.esmoop.2021.100223
First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study
2014 · British Journal of Cancer · 32 citations
https://doi.org/10.1038/bjc.2014.346
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat